Stonepine Capital Management, LLC
CIK 1440771 · Holdings on Sep 30, 2023 · First reported Nov 13, 2023
Top ten holdings
Q3 2023- QDEL15.98%
- EOLS15.72%
- AMLX15.30%
- ADMA10.83%
- LKFT9.21%
- 0162592024.10%
- MXCT3.90%
- XERS3.65%
- M473641002.73%
- ATYR2.43%
Share classes counted separately83.85%
Portfolio value by quarter
Top 10 holdings 23
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | QDELQUIDELORTHO CORP View history and evidence | $48.12M | 15.98% | 658.79K shares | — | ↗▾ | |
| 02 | EOLSEVOLUS INC View history and evidence | $47.34M | 15.72% | 5.18M shares | — | ↗▾ | |
| 03 | AMLXAMYLYX PHARMACEUTICALS INC View history and evidence | $46.07M | 15.30% | 2.52M shares | — | ↗▾ | |
| 04 | ADMAADMA BIOLOGICS INC View history and evidence | $32.59M | 10.83% | 9.10M shares | — | ↗▾ | |
| 05 | LKFTLAKEFRONT BIOTHERAPEUTIC-ADRSPONS ADR View history and evidence | $27.73M | 9.21% | 802.54K shares | — | ↗▾ | |
| 06 | 016259202ALIMERA SCIENCES INCCOM NEW View history and evidence | $12.35M | 4.10% | 3.98M shares | — | ↗▾ | |
| 07 | MXCTMAXCYTE INC View history and evidence | $11.74M | 3.90% | 3.76M shares | — | ↗▾ | |
| 08 | XERSXERIS BIOPHARMA HOLDINGS INC View history and evidence | $11.00M | 3.65% | 5.92M shares | — | ↗▾ | |
| 09 | M47364100GAMIDA CELL LTDSHS View history and evidence | $8.20M | 2.73% | 7.97M shares | — | ↗▾ | |
| 10 | ATYRATYR PHARMA INCCOM NEW View history and evidence | $7.31M | 2.43% | 4.63M shares | — | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 3
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| THRD THIRD HARMONIC BIO INC | Non-derivative | — | — | SEC filing ↗ | |
| URGN UROGEN PHARMA LTD | Non-derivative | — | — | SEC filing ↗ | |
| CSTL CASTLE BIOSCIENCES INC | Non-derivative | — | — | SEC filing ↗ |
3 / 3 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1440771 · Period 2023-09-30
Data loaded 2026-09-23 · First reported 2023-11-13
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 301032343
}Take these holdings further.
This page includes 23 of 23 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 23 of 23 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1440771","quarter":"2023Q3","page_size":100}
get_institutional_manager_history
{"cik":"1440771","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.